Atlas Trials

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

Clinical trial NCT00003091 · COMPLETED

Trial details

NCT number
NCT00003091
Sponsor
Hoag Memorial Hospital Presbyterian
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney CancerMelanoma (Skin)
Start date
1996-01-01
Primary completion
2000-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.